Neurofibromatosis type-1 manifesting with Tourette syndrome

28 downloads 0 Views 63KB Size Report
Tourette syndrome (TS) is an inherited neurological disorder ... The symptoms included eye blinking, arm thrusting, kick- ... There was no similar family history.
Letter to Editor

Letter to Editor

Neurofibromatosis type-1 manifesting with Tourette syndrome Sir, Tourette syndrome (TS) is an inherited neurological disorder with onset below 18 years of age characterized by motor and vocal tics, occurring in 0.6–3% of schoolchildren.[1] The structural basis of TS is incompletely understood. The TS occurring in association with Neurofibromatosis type-1 (NF-1) is a rare feature.[2] However, such a case might provide useful insights into the structural basis of clinical features in TS. A 12-year-old boy presented with multiple motor tics since the age of 5, involving the neck, trunk, upper limbs, and eyelids. The symptoms included eye blinking, arm thrusting, kicking, shoulder shrugging, and jumping. Repeated throat clearing was noted for 18 months. There was no history of seizure, behavioral change, or poor scholastic performance. There were no features to suggest an associated obsessive–compulsive disorder (OCD) or attention deficit hyperactivity disorder (ADHD). There was no similar family history. On examination, multiple café-au-lait macules and axillary freckling were present. Neurological examination was unremarkable. Magnetic resonance imaging (MRI) of the brain showed T2W hyperintense lesions in bilateral basal ganglia [Figure 1] and thalami [Figure 2]. Electroencephalography was normal. The erythrocyte sedimentation rate was 19 mm/h. Serum ceruloplasmin was 96 mg% (normal > 30 mg%). Antinuclear antibody was negative. Serum complement was 80% and antistreptolysin O titer was normal. The TS was diagnosed on the basis of established clinical

Figure 2: T2W axial section of the magnetic resonance imaging (MRI) of the brain of the patient showing hyperintense lesions in the left thalamus

criteria. The child showed significant improvement with risperidone 1 mg, taken twice daily. However, MRI abnormalities persisted even after 6 months. On the basis of the etiology, TS is classified into two categories: idiopathic and symptomatic. Symptomatic TS can occur after head injury, encephalitis, stroke, rheumatic fever, and drug intake (methylphenidate, neuroleptics, opioids, antiepileptics). The neuroanatomical localization of tics has remained a challenging feature. Given the wide clinical heterogeneity in TS and frequent association with OCD or ADHD, several neuroanatomical localizations have been evoked, including the cortex (frontal or temporal lobe), limbic system, basal ganglia, and brain stem. The most favored are the striato-thalamic circuits and striatal compartments.[3] The MRI studies in TS have shown significant reduction in the volumes of caudate and lentiform nucleus. Our patient too had involvement of bilateral caudate and lentiform nuclei [Figure 1]. Therefore, one can speculate that any neurological disease with a significant involvement of caudate or lentiform nuclei or both could present with secondary TS. This argument was strengthened by a recent case of varicella zoster encephalitis with basal ganglia imaging abnormalities, where the patient developed a chronic tic disorder associated with ADHD.[4] In our patient, the basal ganglia abnormalities were related to NF1, a feature that has been well described.[5] Hyperintense lesions in the basal ganglia in patients with NF-1, may regress over time in 40% of patients, and this might suggest that these lesions are due to demyelination.[5] In conclusion, TS can result from a variety of causes, NF-1 being an uncommon cause. Our case and data from previous reports point towards the pathological involvement of caudate and lentiform nuclei in the genesis of tics in TS. Tics in secondary TS too respond well to risperidone.

Sudhir Kumar Figure 1: T2W axial section of the magnetic resonance imaging (MRI) of the brain of the patient showing hyperintense lesions in bilateral caudate and lentiform nuclei, right more than left

Neurology India | September 2005 | Vol 53 | Issue 3

Department of Neurological Sciences, Christian Medical College, Vellore, Tamilnadu – 632004, India, E-mail: [email protected] 361 CMYK361

Letter to Editor

References 1.

2. 3.

4. 5.

Wang HS, Kuo MF. Tourette’s syndrome in Taiwan. An epidemiological study of tic disorders in an elementary school at Taipei County. Brain Dev 2003;25:S29-31. Cosentino C, Torres L. Tourette’s syndrome and neurofibromatosis type 1. Pediatr Neurol 2000;22:420-1. Singer HS, Minzer K. Neurobiology of Tourette’s syndrome. Concepts of neuroanatomic localization and neurochemical abnormalities. Brain Dev 2003;25:S70-84. Dale RC, Church AJ, Heyman I. Striatal encephalitis after varicella zoster infection complicated by Tourettism. Mov Disord 2003;18:1554-6. Menor F, Marti-Bonmati L, Arana E, Poyatos C, Cortina H. Neurofibromatosis type 1 in children. MR imaging and follow-up studies of the central nervous system findings. Eur J Radiol 1998;26:121-31.

Accepted on 26-08-2004

Punding in Parkinson’s disease related to high-dose levodopa therapy Sir, A 69-year-old lady a case of idiopathic Parkinson’s disease (PD) was brought with one-month history of repeated and excessive arranging and counting of dresses. The patient spent a lot of time searching for clothes and dresses and meticulously arranging them according to their sizes. She would repeatedly count them. She would get up from sleep and repeat this act for several hours. On questioning, the patient agreed that her act of this was irrational and unproductive, however, expressed an inability to control her from doing so. She was on levodopa for 13 years and the dose had been gradually increased to 1000 mg per day. It was discovered that she was taking an additional dose of 500 mg per day on her own. Other medications included bromocriptine 5 mg, selegeline 10 mg, and trihexiphenydyl 6 mg daily. The duration of levodopa effect had gradually decreased from initial six hours to one-two hours at the time of presentation. “Peakdose” dyskinesias were also noted. Clinical examination was unremarkable except for hyperreflexia. She had mild autonomic dysfunction but no dementia. Computerized tomography of the brain, electroencephalography, routine hemogram and biochemistry were normal. A possible diagnosis of punding and dyskinesias related to high-dose levodopa was made. Levodopa dose was reduced to 750 mg daily and amantadine 100 mg thrice daily was added. She had a good response and punding subsided within three days. “Punding” is a stereotypical motor behavior in which there is an intense fascination with repetitive handling and examining of mechanical objects, such as picking at oneself or taking apart watches and radios or sorting and arranging of com362 362 CMYK

mon objects, such as lining up pebbles, rocks, or other small objects.[1] Punding differs from compulsions in that performance of these activities is not distressing to patients and it is only if the act is interrupted that any compulsive urge becomes apparent.[2] Punding is well known to occur in association with addiction to central stimulant drugs such as amphetamine or cocaine.[3] Punding on levodopa therapy was initially reported by Friedman about 10 years ago. However, there is not much data available on this topic yet. The previously reported cases were women in the age group 65-72 years, similar to our case.[1] The duration of disease was 1020 years and they were receiving levodopa at a dose of 5001900 mg per day, which is similar to our case. Symptoms subsided after decreasing the dose of levodopa in all. Therefore, punding is thought to be related to excessive dopaminergic stimulation. The brain region most likely involved in mediating these effects involves mesolimbic dopaminergic projections and the nucleus accumbens.[4] Regional cerebral blood flow studies using positron emission tomography have shown that dopaminergic effects on orbitofrontal cortex via dopamine D3 receptors may in part cause punding and other complex dopamine-induced stereotypies.[5] Punding in PD is not a specific problem related to levodopa, as cases with punding have been described in association with quetiapine (an atypical antipsychotic) used for treating psychosis in PD.[6] In conclusion, one should be aware of the possibility of punding in patients with PD on long-term dopaminergic therapy, especially levodopa. As punding is not distressing to the patient, the history may not be volunteered. Failure to recognize this early may be a source of discomfort to the patient and carergivers, whereas early diagnosis can result in prompt relief of symptoms.

Sudhir Kumar Department of Neurological Sciences, Neurology Unit, Christian Medical College, Vellore, Tamilnadu, India E-mail: [email protected]

References 1. 2. 3. 4. 5.

6.

Fernandez HH, Friedman JH. Punding on L-dopa. Mov Disord 1999;14:836-8. Rylander G. Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 1972;75:203-12. Schiorring E. Psychopathology induced by “speed drugs”. Pharmacol Biochem Behav 1981;14:109-22. Cummings JL. A window on the role of dopamine in addiction disorders. J Neurol Neurosurg Psychiatry 2000;68:404. Black KJ, Hershey T, Koller JM, Videen TO, Mintun MA, Price JL, et al. A possible substrate for dopamine-related changes in mood and behavior: Prefrontal and limbic effects of a D3-preferring dopamine agonist. USA: Proc Natl Acad Sci; 2002;99:17113-8. Miwa H, Morita S, Nakanishi I, Kondo T. Stereotyped behaviors or punding after quetiapine administration in Parkinson’s disease. Parkinsonism Relat Disord 2004;10:177-80.

Accepted on 14-09-2004

Neurology India | September 2005 | Vol 53 | Issue 3